Search Results - "Udwadia, F"

Favipiravir: A new and emerging antiviral option in COVID-19 by Agrawal, Umang, Raju, Reyma, Udwadia, Zarir F.

“…With over 16 million cases reported from across the globe, the SARS-CoV-2, a mere 125 microns in diameter, has left an indelible impact on our world. With the…”
Get full text

Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial by Udwadia, Zarir F., Singh, Pawan, Barkate, Hanmant, Patil, Saiprasad, Rangwala, Shabbir, Pendse, Amol, Kadam, Jatin, Wu, Wen, Caracta, Cynthia F., Tandon, Monika

“…•Favipiravir is an oral RNA-dependent RNA polymerase inhibitor.•Favipiravir is under investigation in many countries for the treatment of COVID-19.•We…”
Get full text

MDR, XDR, TDR tuberculosis: ominous progression by Udwadia, Zarir F

Get more information

Totally Drug-Resistant Tuberculosis in India by Udwadia, Zarir F., Amale, Rohit A., Ajbani, Kanchan K., Rodrigues, Camilla

Get full text

Post-COVID lung fibrosis: The tsunami that will follow the earthquake by Udwadia, Zarir, Koul, Parvaiz, Richeldi, Luca

“…The SARS-CoV-2 pandemic has already infected in excess of 50 million people worldwide and resulted in 1.2 million deaths. While the majority of those infected…”
Get full text

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis by SOTGIU, Giovanni, CENTIS, Rosella, SCHECTER, Giesela F, SHIM, Tae S, SINGLA, Rupak, SKRAHINA, Alena, SPANEVELLO, Antonio, UDWADIA, Zarir F, VILLAR, Miquel, ZAMPOGNA, Elisabetta, ZELLWEGER, Jean-Pierre, ZUMLA, Alimuddin, D'AMBROSIO, Lia, MIGLIORI, Giovanni Battista, ALFFENAAR, Jan-William C, ANGER, Holly A, CAMINERO, Jose A, CASTIGLIA, Paolo, DE LORENZO, Saverio, FERRARA, Giovanni, KOH, Won-Jung

“…Linezolid is used off-label to treat multidrug-resistant tuberculosis (MDR-TB) in absence of systematic evidence. We performed a systematic review and…”
Get full text

Audio Interview: India’s Covid-19 Crisis by Rubin, Eric J, Baden, Lindsey R, Udwadia, Zarir F, Morrissey, Stephen

“…In this audio interview conducted on May 4, 2021, the editors are joined by Mumbai pulmonologist Zarir Udwadia, who assesses the current surge of Covid-19…”
Get full text

Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades? by Udwadia, Zarir F, Pinto, Lancelot M, Uplekar, Mukund W

“…Mumbai, India. A study conducted in Mumbai two decades ago revealed the extent of inappropriate tuberculosis (TB) management practices of private…”
Get full text

Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009–2016 by Cegielski, J Peter, Chan, Pei-Chun, Lan, Zhiyi, Udwadia, Zarir F, Viiklepp, Piret, Yim, Jae-Joon, Menzies, Dick

“…Abstract Background As new drugs are developed for multidrug-resistant tuberculosis (MDR-TB), the role of currently used drugs must be reevaluated. Methods We…”
Get full text

Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India by Udwadia, Zarir F, Ganatra, Shashank, Mullerpattan, Jai B

“…Bedaquiline, a mycobacterial ATP synthase inhibitor [1], is the first new tuberculosis (TB) drug in almost 50 years. So far, over 800 patients have received…”
Get full text

Treating household contacts of MDR-TB patients: Are we being too hasty? by Udwadia, Zarir, Tripathi, Awatansh, Patel, Jigneshkumar

Get full text

Correction to: Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China by Richeldi, Luca, Rubin, Adalberto Sperb, Avdeev, Sergey, Udwadia, Zarir F, Xu, Zuo Jun

Get full text

Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis by Lan, Zhiyi, Ahmad, Nafees, Baghaei, Parvaneh, Barkane, Linda, Benedetti, Andrea, Brode, Sarah K, Brust, James C M, Campbell, Jonathon R, Chang, Vicky Wai Lai, Falzon, Dennis, Guglielmetti, Lorenzo, Isaakidis, Petros, Kempker, Russell R, Kipiani, Maia, Kuksa, Liga, Lange, Christoph, Laniado-Laborín, Rafael, Nahid, Payam, Rodrigues, Denise, Singla, Rupak, Udwadia, Zarir F, Menzies, Dick, Ahmad, N, Baghaei, P, Barkane, L, Benedetti, A, Brode, SK, Brust, JCM, Campbell, JR, Chang, VWL, Falzon, D, Guglielmetti, L, Isaakidis, P, Kempker, RR, Kipiani, M, Kuksa, L, Lan, Z, Lange, C, Laniado-Laborín, R, Nahid, P, Rodrigues, D, Singla, R, Udwadia, ZF, Menzies, D

“…Treatment of multidrug-resistant tuberculosis requires long-term therapy with a combination of multiple second-line drugs. These drugs are associated with…”
Get full text

Point-of-care breath test for biomarkers of active pulmonary tuberculosis by Phillips, Michael, Basa-Dalay, Victoria, Blais, Jaime, Bothamley, Graham, Chaturvedi, Anirudh, Modi, Kinjal D, Pandya, Mauli, Natividad, Maria Piedad R, Patel, Urvish, Ramraje, Nagsen N, Schmitt, Peter, Udwadia, Zarir F

“…Summary Rationale Volatile organic compounds (VOCs) in breath provide biomarkers of tuberculosis (TB) because Mycobacterium tuberculosis manufactures VOC…”
Get full text

Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic by Udwadia, Zarir F, Tornheim, Jeffrey A, Ganatra, Shashank, DeLuca, Andrea, Rodrigues, Camilla S, Gupta, Amita

“…India has the world's highest tuberculosis burden, and Mumbai is particularly affected by multidrug resistant tuberculosis (MDR-TB). WHO recommends short,…”
Get full text

New treatments for Drug Resistant TB: Past imperfect, future bright by Udwadia, Zarir, Patel, Jigneshkumar

Get full text

Response to the comments received on article “Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial” by Udwadia et al by Udwadia, Zarir F., Barkate, Hanmant, Patil, Saiprasad, Rangwala, Shabbir, Wu, Wen, Caracta, Cynthia F., Tandon, Monika

Get full text

Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy by Udwadia, Zarir, Pawar, Unmesha, Nanda, Viral

Get full text

Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India by Resendiz-Galvan, Juan Eduardo, Arora, Prerna R, Abdelwahab, Mahmoud Tareq, Udwadia, Zarir F, Rodrigues, Camilla, Gupta, Amita, Denti, Paolo, Ashavaid, Tester F, Tornheim, Jeffrey A

“…Linezolid is an oxazolidinone used to treat multidrug-resistant tuberculosis (MDR-TB), including in the recently-endorsed shorter 6-month treatment regimens…”
Get full text

A new perspective on the tracking control of nonlinear structural and mechanical systems by Udwadia, F. E.

“…Based on recent results from analytical dynamics, this paper develops a class of tracking controllers for controlling general, nonlinear, structural and…”
Get full text